Russell Investments Group, Ltd. Omeros Corp Transaction History

Russell Investments Group, Ltd.

$69.8 Billion
Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Omeros Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,091 shares of OMER stock, worth $9,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,091

Previous 152 617.76%

Holding current value

$9,949

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.77 - $12.15 $3,540 - $11,408	939 Added 617.76%	1,091 $10,000
Q3 2024 Nov 13, 2024	SELL	$3.54 - $5.47 $6,453 - $9,971	-1,823 Reduced 92.3%	152 $0
Q2 2024 Aug 08, 2024	BUY	$3.04 - $4.23 $6,004 - $8,354	1,975 New	1,975 $8,000
Q1 2021 May 10, 2021	SELL	$14.52 - $23.53 $277,041 - $448,952	-19,080 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$10.14 - $15.19 $64,064 - $95,970	-6,318 Reduced 24.88%	19,080 $272,000
Q3 2020 Nov 09, 2020	BUY	$9.57 - $21.32 $243,058 - $541,485	25,398 New	25,398 $256,000
Q2 2020 Aug 05, 2020	SELL	$12.21 - $16.99 $36,630 - $50,969	-3,000 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$13.01 - $17.15 $39,030 - $51,449	3,000 New	3,000 $41,000
Q3 2018 Oct 26, 2018	SELL	$17.73 - $26.69 $529,843 - $797,603	-29,884 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$9.0 - $20.16 $63,333 - $141,865	7,037 Added 30.8%	29,884 $334,000
Q4 2017 Feb 06, 2018	SELL	$13.26 - $22.86 $65,398 - $112,745	-4,932 Reduced 17.75%	22,847 $447,000
Q3 2017 Nov 07, 2017	BUY	$19.76 - $24.9 $548,913 - $691,697	27,779	27,779 $601,000

Others Institutions Holding OMER

# of Institutions

133

Shares Held

25.1M

Call Options Held

228K

Put Options Held

624K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $572M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Omeros Corp Transaction History